Sep 20, 2023 / 07:00PM GMT
Laura E. Niklason - Humacyte, Inc. - Founder, President, CEO & Director
Everybody for coming. I'm really glad that we had a chance to walk through some of these things in person and that you can hear some viewpoints from Dr. Curi. I'm going to talk a little bit about our clinical trial results, which we actually announced in a virtual forum last week. But in addition to that, Dr. Curi is going to talk about a few cases that he's cared for with the HAV in the Trauma trial. And then we're also very fortunate to have Devin and her mother here. So Devin was a patient who was actually working on the doc's in New Jersey. I don't want to spill too much of your story, but Dr. Curi treated her in this trial as well. And if you notice, she's standing on some fabulous ideal. So I just want to get that across right...
Unidentified Analyst -
(inaudible)
Laura E. Niklason - Humacyte, Inc. - Founder, President, CEO & Director
Speak into the microphone. Yes. Okay. Can they hear better now? Are we hearing better now? Excellent. All
Humacyte Inc To Host KOL And Patient Perspectives Event Transcript
Sep 21, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers